Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a ...

A new study finds that children with acute lymphoblastic leukaemia (ALL) who remain overweight or obese during treatment face ...

Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia ...

Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy ...

The overall prevalence of comorbidity among pediatric patients diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) varies by biological sex at birth, and additional ...

Haddie Honeycutt is just 4 years old and bursts with energy as she continues her battle with leukemia. And she’s surrounded by a full house and love and support through it all. We spoke with her mom ...

A local St. Jude patient and his family share his cancer journey. In August 2023, right after Jaxon started fifth grade, he ...

Moleculin is in the process of updating its iPSP to incorporate FDA’s recommendations and intends to submit the revised plan to FDA later this quarter. Moleculin expects to initiate pediatric clinical ...

Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...